Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 15 August

Grady Wulff
August 15, 2022

Weekly Wrap 12 August

Sophia Mavridis
August 12, 2022

Morning Bell 11 August

Paulina Peters
August 11, 2022

Morning Bell 10 August

Sophia Mavridis
August 10, 2022

Morning Bell 9 August

Paulina Peters
August 9, 2022

Morning Bell 8 August

Sophia Mavridis
August 8, 2022

Weekly Wrap 5 August

Sophia Mavridis
August 5, 2022

Morning Bell 4 August

Paulina Peters
August 4, 2022

Morning Bell 3 August

Sophia Mavridis
August 3, 2022

Morning Bell 2 August

Paulina Peters
August 2, 2022